GSK plc - Aug 7, 2025 SCHEDULE 13D Report for CureVac N.V. Common Shares, par value (euro) 0.12 per share (CVAC)

Filing Manager: GSK plc
Reporting Manager: GSK plc
Security: CureVac N.V. Common Shares, par value (euro) 0.12 per share
Symbol: CVAC
Shares outstanding: 22.4M shares
Disclosed Ownership: 16.6M shares
Ownership: 74%
Form type: SCHEDULE 13D
Date filed: 8/13/2025, 06:05 PM
Date of event: Aug 7, 2025
Next filing: Dec 5, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
GSK plc	74%	16.6M	16.6M	0	/s/ Victoria A. Whyte	Victoria A. Whyte, Authorized Signatory	0001131399